艾昆纬- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于艾昆纬公司

艾昆纬. 是生命科学行业高级分析、技术解决方案和临床研究服务提供商。其部门包括技术与分析解决方案、研发解决方案和合同销售与医疗解决方案。技术与分析解决方案部门为其生命科学客户提供关键任务信息、技术解决方案和现实世界的见解和服务。研发解决方案部门为生物制药客户提供服务，并提供外包临床研究和临床试验相关服务。合同销售与医疗解决方案部门为生物制药客户和更广泛的医疗保健市场提供医疗保健提供商（包括合同销售）和患者参与服务。其 Connected Intelligence 提供见解和解决方案，使客户能够加速医疗治疗的临床开发和商业化，从而改善患者的医疗保健结果。

艾昆纬简介



公司代码IQV

公司名称IQVIA Holdings Inc

上市日期May 09, 2013

CEOMr. Ari Bousbib

员工数量88000

证券类型Ordinary Share

年结日May 09

公司地址2400 Ellis Road

城市DURHAM

上市交易所NYSE Consolidated

国家United States of America

邮编27703

电话19199982000

网址https://ir.iqvia.com/

公司代码IQV

上市日期May 09, 2013

CEOMr. Ari Bousbib

艾昆纬公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.35M

--

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

46.46K

-1.91%

Mr. John G. Danhakl

Independent Director

30.85K

-79.16%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

21.11K

--

Ms. Colleen A. Goggins

Independent Director

16.83K

+10.45%

Dr. John M. Leonard, M.D.

Lead Independent Director

15.38K

+11.55%

Ms. Carol J. Burt

Independent Director

7.01K

+17.56%

Mr. James A. Fasano

Independent Director

2.74K

+157.67%

Mr. John P. Connaughton

Independent Director

1.05K

--

Mr. Bhavik Patel

President, Commercial Solutions

863.00

-8.87%

名称

名称/职务

职务

持股

持股变动

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.35M

--

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

46.46K

-1.91%

Mr. John G. Danhakl

Independent Director

30.85K

-79.16%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

21.11K

--

Ms. Colleen A. Goggins

Independent Director

16.83K

+10.45%

Dr. John M. Leonard, M.D.

Lead Independent Director

15.38K

+11.55%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

暂无数据

地区USD

名称

营收

占比

Americas

1.94B

48.17%

Europe & Africa Region

1.24B

30.89%

Asia Pacific Region

841.00M

20.94%

业务

地区

暂无数据

股东统计

更新时间: 10月31日周五

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

11.40%

Harris Associates L.P.

6.90%

BlackRock Institutional Trust Company, N.A.

5.50%

State Street Investment Management (US)

4.48%

GIC Private Limited

3.84%

其他

67.88%

持股股东

占比

The Vanguard Group, Inc.

11.40%

Harris Associates L.P.

6.90%

BlackRock Institutional Trust Company, N.A.

5.50%

State Street Investment Management (US)

4.48%

GIC Private Limited

3.84%

其他

67.88%

股东类型

持股股东

占比

Investment Advisor

48.20%

Investment Advisor/Hedge Fund

34.87%

Hedge Fund

7.16%

Sovereign Wealth Fund

4.96%

Pension Fund

4.16%

Research Firm

2.49%

Bank and Trust

2.06%

Individual Investor

0.91%

Family Office

0.13%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

2061

175.98M

103.33%

-829.63K

2025Q2

2053

166.70M

98.05%

-9.45M

2025Q1

2083

168.53M

97.38%

-9.36M

2024Q4

2059

171.87M

97.45%

+3.00M

2024Q3

2008

173.01M

95.44%

+863.78K

2024Q2

1977

164.85M

90.43%

-7.68M

2024Q1

1950

165.50M

90.84%

-10.38M

2023Q4

1948

168.90M

93.03%

-6.38M

2023Q3

1925

170.01M

92.82%

-4.41M

2023Q2

1898

167.84M

91.62%

-8.26M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

19.60M

11.53%

-162.29K

-0.82%

Jun 30, 2025

Harris Associates L.P.

11.75M

6.91%

+583.80K

+5.23%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

9.37M

5.51%

-507.18K

-5.13%

Jun 30, 2025

State Street Investment Management (US)

7.62M

4.49%

-98.36K

-1.27%

Jun 30, 2025

GIC Private Limited

6.54M

3.85%

-2.59M

-28.36%

Mar 31, 2025

Geode Capital Management, L.L.C.

4.22M

2.48%

-16.90K

-0.40%

Jun 30, 2025

CPP Investments

4.17M

2.45%

-426.35K

-9.28%

Jun 30, 2025

Farallon Capital Management, L.L.C.

3.85M

2.27%

+439.50K

+12.88%

Jun 30, 2025

AllianceBernstein L.P.

3.56M

2.09%

+19.57K

+0.55%

Jun 30, 2025

Artisan Partners Limited Partnership

3.27M

1.93%

+3.27M

--

Jun 30, 2025

持股ETF



更新时间: 11月6日周四

机构名称

占比

First Trust Nasdaq Lux Digi Health Solutions ETF

7.97%

Global X HealthTech ETF

5.5%

VanEck Biotech ETF

4.63%

Langar Global HealthTech ETF

4.46%

Adaptive Core ETF

3.04%

iShares Biotechnology ETF

3.03%

iShares ESG Aware MSCI USA Value ETF

2.37%

Invesco Bloomberg Pricing Power ETF

1.96%

American Century Focused Large Cap Value ETF

1.93%

Running Oak Efficient Growth ETF

1.87%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比7.97%

Global X HealthTech ETF

占比5.5%

VanEck Biotech ETF

占比4.63%

Langar Global HealthTech ETF

占比4.46%

Adaptive Core ETF

占比3.04%

iShares Biotechnology ETF

占比3.03%

iShares ESG Aware MSCI USA Value ETF

占比2.37%

Invesco Bloomberg Pricing Power ETF

占比1.96%

American Century Focused Large Cap Value ETF

占比1.93%

Running Oak Efficient Growth ETF

占比1.87%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

艾昆纬

关于 艾昆纬 公司

艾昆纬简介

艾昆纬公司高管

收入明细

股东统计

机构持股

股东持股明细

持股ETF

分红派息

拆合股

关于艾昆纬公司